RhumbLine Advisers’s iBio IBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-455
| Closed | -$97K | – | 3158 |
|
|
2022
Q1 | $97K | Sell |
455
-55
| -11% | -$11.7K | ﹤0.01% | 2890 |
|
|
2021
Q4 | $140K | Sell |
510
-9
| -2% | -$2.47K | ﹤0.01% | 2899 |
|
|
2021
Q3 | $275K | Buy |
519
+15
| +3% | +$7.95K | ﹤0.01% | 2800 |
|
|
2021
Q2 | $381K | Buy |
504
+205
| +69% | +$155K | ﹤0.01% | 2680 |
|
|
2021
Q1 | $230K | Buy |
299
+85
| +40% | +$65.4K | ﹤0.01% | 2796 |
|
|
2020
Q4 | $112K | Buy |
214
+121
| +130% | +$63.3K | ﹤0.01% | 2956 |
|
|
2020
Q3 | $95K | Buy |
93
+4
| +4% | +$4.09K | ﹤0.01% | 2877 |
|
|
2020
Q2 | $99K | Buy |
+89
| New | +$99K | ﹤0.01% | 2971 |
|